action of glp-1 agonist A Closer Look at the Dermatological Profile Agonists Mechanism of action of GLP-1
Description
In the SUSTAIN-6 trial, injectable semaglutide demonstrated a notable effect in reducing the incidence of nonfatal stroke (hazard ratio [HR] 0.61
These drugs may not be cost-effective
Certain patient factors may increase susceptibility to constipation on GLP-1 therapy
A good bariatric recommendation should be individualized
Perlis, L
USA 114 , E5266E5275 (2017)
